Imaging findings,pathological findings and differential diagnosis of myxoid glioneuronal tumor
Myxoid glioneuronal tumor(MGT)is a rare benign glioneuronal tumor newly defined in the 5th edition of 2021 WHO Classification of Central nervous System Tumors,which belongs to WHO grade I.In the past,MGT was diagnosed as"dysembryoplastic neuroepithelial tumor in the septum pellucidum"due to its histological similarity to dysembryoplastic neuroepithelial tumor.With the advancement of technology,there has been a new development in imaging,pathology,and genetic detection of the researches on MGT,especially the hot spot mutation at the Lys385 codon of PDGFRA,which defines MGT as a new type of glioma.This review summarizes the clinical manifestations,imaging manifestations,pathological characteristics and genetic test results of MGT and integrate the differential diagnosis of diseases that may be misdiagnosed,proposing research directions and potential therapeutic method of this disease,aiming to provide help for the diagnosis and treatment of MGT,and reduce the missed diagnosis and misdiagnosis of this disease.
国家科技期刊平台
NSTL
万方数据
